Baxa Ltd. has launched the CyTwo-Fer Needle, featuring a unique hub design that provides vented access to vials or non-vented access to IV bags, performing the work of two devices. Both bags and vials may then be accessed in one procedure - avoiding the expense and time involved in changing needles. Designed to prevent environmental contamination during cytotoxic drug reconstitution, the CyTwo-Fer Needle has a 0.2 micron vent filter, allowing safe and efficient vial reconstitution, aspiration and subsequent injection of drugs into bags or other IV delivery devices.
Ascot, Berkshire (PRWEB) November 3, 2004 -- Baxa Ltd. announces the launch of the CyTwo-Fer Needle, featuring a unique hub design that provides vented access to vials or non-vented access to IV bags, performing the work of two devices. Both bags and vials may then be accessed in one procedure - avoiding the expense and time involved in changing needles.
The CyTwo-Fer Needle features a 16G stainless steel cannula with a Huber point for smooth and safe vial access, without the coring often associated with plastic spike devices. The Huber point also allows users to direct liquid flow into the vial to reduce foaming during admixture.
Designed to prevent environmental contamination during cytotoxic drug reconstitution, the CyTwo-Fer Needle has a 0.2 micron vent filter, allowing safe and efficient vial reconstitution, aspiration and subsequent injection of drugs into bags or other IV delivery devices. This filtered vent balances air pressure in the vial or container for fast and easy liquid addition and removal, minimising the risk of upper limb disorder. Finger grips and a tethered cap also facilitate ease of use.
"With this dual-purpose needle, Baxa makes the reconstitution process safer for technicians handling hazardous drugs," says Terry Aston, Managing Director for Baxa Ltd. "Its high-flow vent filter traps potentially harmful aerosol particles during reconstitution."
CyTwo-Fer Needles are available for sale now in Europe, the Middle East and Africa - directly through Baxa Ltd. or through dealer representatives. For more information, check the product section of http://www.baxa.com or contact Baxa Ltd.
Photos available on request.
About Baxa Corporation
As a leading provider of devices and systems for the preparation, handling, packaging, and administration of liquid medications, Baxa manufactures and markets a wide range of healthcare products for use in hospitals, critical care units and alternate-site pharmacies. Baxa Ltd. is a wholly owned subsidiary of Baxa Corporation, headquartered in Englewood, Colorado. Baxa has locations in Canada, Denmark and Germany, and distribution partners worldwide. Further information is available at http://www.baxa.com.
Contact:
Stephanie Scott, Marketing Manager, Baxa Ltd.
Tel: +44 (0) 1344 890916 or Fax: +44 (0) 1344 890917
email: s.scott@baxa.co.uk
# # #
|
